透明質酸注射治療關節痛的市場規模及預測

Hyaluronic Acid Injections For Joint Pain Market Size And Forecast

出版日期: 2025年05月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年用於治療關節痛的透明質酸注射劑市場規模為 44.1 億美元，預計到 2032 年將達到 69.9 億美元，2026 年至 2032 年的複合年成長率為 5.93%。

推動全球透明質酸注射劑治療關節疼痛市場的因素

用於治療關節痛的透明質酸注射劑市場的市場促進因素可能受到多種因素的影響。

人口老化：隨著全球人口老化，骨關節炎等關節相關疾病日益普遍。玻尿酸注射是一種微創治療方法，可以緩解關節不適並改善關節功能，滿足老化社會的需求。骨關節炎是最常見的關節炎類型，影響全球數百萬人。其發病率正在上升。由於老齡化、肥胖和久坐不動的生活方式等因素，骨關節炎變得越來越普遍，因此對透明質酸注射等有效治療方案的需求也日益成長，以減輕關節不適並改善活動能力。
偏好非手術治療：在接受關節重建等侵入性手術之前，許多患者更傾向於採用非手術方法來緩解關節不適。玻尿酸注射是一種非侵入性治療關節疼痛、緩解不適並改善關節功能的方法，無需承擔手術帶來的風險和漫長的恢復期。
技術發展：醫療技術的進步使得透明質酸注射劑型和給藥方法更加完善。這些進步提高了治療的有效性、安全性和患者舒適度，從而提高了患者和醫護人員的接受度。
注重疼痛管理和生活品質提升：骨關節炎等慢性疾病患者越來越重視疼痛管理和生活品質提升。玻尿酸注射可以幫助患者有針對性地控制疼痛，繼續日常活動，並擁有更美好的生活。
醫療基礎設施不斷成長：醫療基礎設施的不斷成長，尤其是在新興經濟體，促進了人們獲得諸如透明質酸注射等治療關節疼痛的醫療療法。這種擴張使得關節問題的診斷和治療變得更加容易，從而擴大了相關治療和療法的市場。
醫療保健支出不斷成長：隨著個人和政府醫療保健支出的增加，用於治療關節疼痛的透明質酸注射市場正在不斷擴大。玻尿酸注射及相關療法的市場成長動力源自於患者願意花錢購買能改善整體生活品質並有效緩解疼痛的療法。
臨床證據和患者滿意度：越來越多的臨床證據表明透明質酸注射治療關節疼痛的安全性和有效性，以及積極的患者體驗和療效，正在推動市場擴張。經過深入研究並被證明真正有效的治療方法更有可能被患者和醫療保健專業人員採用。

限制透明質酸注射劑治療關節痛的全球市場的因素

多種因素可能會對玻尿酸注射治療關節痛市場造成限制和挑戰。

治療費用高昂：玻尿酸注射費用較高，尤其需要長期重複注射的患者。高昂的費用可能會阻礙患者獲得治療，尤其是對於缺乏足夠保險或經濟能力的患者。
保險覆蓋範圍有限：在某些地區，透明質酸注射的保險覆蓋範圍可能很少或不穩定，這可能會限制患者獲得治療的機會，因為患者必須自掏腰包支付治療費用，特別是如果他們沒有健康保險或收入較低。
療效差異：透明質酸注射的效果因人而異。有些人的疼痛得到顯著緩解，關節功能得到改善，而有些人的療效則僅有輕微改善。這種治療效果的差異可能會導致患者不滿意，並不願意再注射。
與替代療法的競爭：皮質類固醇注射、物理治療、口服藥物、關節關節重建手術和其他替代療法在治療關節不適方面與透明質酸注射療法構成競爭。如果患者和相關人員因為成本、有效性和侵入性而選擇這些替代療法，那麼透明質酸注射療法的市場潛力可能不那麼高。
監管障礙：透明質酸注射的監管要求和核准存在地區差異，這可能會阻礙市場進入和成長。製造商在獲得產品監管批准方面遇到問題和延誤，可能會延緩市場擴張。雖然透明質酸注射劑通常被認為是安全的，但人們可能擔心其可能出現的副作用，包括過敏反應、感染疾病和注射部位反應。安全問題可能會削弱患者對治療過程的信心，並使醫療保健專業人員不願開立或實施透明質酸注射。
缺乏長期數據：目前尚不清楚玻尿酸注射在一定療程後是否長期安全有效。缺乏強力的長期證據可能會引起患者和醫療保健專業人士對治療效果的長期永續性產生懷疑，從而可能阻礙市場擴張。
負面社會認知：儘管有臨床證據支持透明質酸注射的有效性，但某些公眾群體仍可能對其抱持懷疑或負面看法。與替代療法以及關節疾病自然發展的觀點相比，這種看法尤其明顯。負面認知可能會影響患者的選擇和醫療專業人士的建議。

Ageing Population: As people get older worldwide, joint-related conditions like osteoarthritis are more common. The ageing population's needs are met by hyaluronic acid injections, a less invasive therapy option for joint discomfort and improved joint function. Osteoarthritis is the most prevalent type of arthritis, impacting millions of individuals globally. Its incidence is on the rise. Because osteoarthritis is becoming more common due to factors including ageing, obesity, and sedentary lifestyles, there is a growing need for efficient treatment options, such as injections of hyaluronic acid, to reduce joint discomfort and increase mobility.
Preference for Non-Surgical Treatments: Before pursuing invasive procedures like joint replacement surgery, many patients would rather address their joint discomfort non-surgically. Injections of hyaluronic acid offer a non-invasive way to treat joint pain, relieving discomfort and enhancing joint performance without the dangers and extended recuperation period of surgery.
Technological Developments: Better hyaluronic acid injectable formulations and delivery methods have been made possible by developments in medical technology. These developments increase the treatment's effectiveness, safety, and patient comfort, which encourages patients and healthcare professionals to accept it.
Emphasis on Pain Management and Enhancing Quality of Life: Patients with chronic illnesses like osteoarthritis are experiencing a greater emphasis on pain management and enhancing their quality of life. With the help of hyaluronic acid injections, patients can manage their pain in a targeted manner, continue with their everyday activities, and live better.
Growing Healthcare Infrastructure: Access to medical therapies, such as joint pain injections using hyaluronic acid, is made easier by the growth of healthcare infrastructure, especially in emerging nations. The market for associated therapies and treatments is growing as a result of this expansion, which makes joint problems easier to diagnose and treat.
Growing Healthcare Spending: The market for hyaluronic acid injections for joint pain is expanding as a result of growing healthcare spending by both individuals and governments. The market for hyaluronic acid injections and related therapies is driven by patients' willingness to spend money on therapies that enhance their overall quality of life and provide efficient pain relief.
Clinical Evidence and Patient Satisfaction: Positive patient experiences and outcomes, in addition to mounting clinical evidence demonstrating the safety and effectiveness of hyaluronic acid injections for joint pain, drive market expansion. Treatments that have been thoroughly researched and demonstrated to have real benefits are more likely to be adopted by patients and healthcare professionals.

Global Hyaluronic Acid Injections For Joint Pain Market Restraints

Several factors can act as restraints or challenges for the Hyaluronic Acid Injections For Joint Pain Market. These may include:

Exorbitant Treatment Costs: Hyaluronic acid injections can be somewhat expensive, particularly for people who need repeated injections over time. Access to therapy may be hampered by this high cost, especially for those without sufficient insurance or financial means.
Restricted Insurance Coverage: Hyaluronic acid injection insurance coverage may be scarce or erratic in certain areas. Patients may have to pay for this out of cash, which would limit their access to the treatment-especially if they don't have full health insurance or have a poor income.
Efficacy Variability: The results of hyaluronic acid injections can differ from patient to patient. While some may experience considerable pain alleviation and improved joint function, others may only see minor improvements. Patients may become dissatisfied and reluctant to have repeat injections as a result of this variation in therapy response.
Competition from Alternative Therapies: Corticosteroid injections, physical therapy, oral drugs, joint replacement surgery, and other alternative treatments are competitors for hyaluronic acid injections as treatments for joint discomfort. Hyaluronic acid injections may not have as much market potential as they could if patients and healthcare professionals choose these alternative therapies due to considerations including cost, efficacy, and invasiveness.
Regulatory Obstacles: Market entry and growth may be hampered by regional variations in the regulatory requirements and approvals for hyaluronic acid injections. The expansion of the market may be slowed down by manufacturers running into problems or delays getting regulatory permission for their products. Hyaluronic acid injections are thought to be safe overall, however there may be worries about possible adverse effects such allergic responses, infections, or reactions at the injection site. Concerns about safety can undermine patients' trust in the course of treatment and make medical professionals reluctant to prescribe or carry out hyaluronic acid injections.
Absence of Long-Term Data: It is unclear if hyaluronic Acid Injections are safe and effective in the long run after a certain amount of treatment. The absence of strong long-term evidence may impede market expansion by raising doubts about the long-term sustainability of treatment benefits among patients and healthcare professionals.
Negative Public Perception: Hyaluronic acid injections may encounter scepticism or negative perceptions from certain public segments despite clinical evidence supporting their efficacy. This is especially true when comparing their worth to alternative treatments or the belief that joint conditions naturally progress. Adverse impressions have the potential to impact both patient choices and medical professional advice.

Global Hyaluronic Acid Injections For Joint Pain Market Segmentation Analysis

The Global Hyaluronic Acid Injections For Joint Pain Market is Segmented on the basis of Type, Application, And Geography.

Hyaluronic Acid Injections For Joint Pain Market, By Type

Knee and Ankle
Hip Joint
Others

Based on Type, the market is segmented into Knee and Ankle, Hip Joint, and Others. Knee and Ankle type is leading with the highest share in the market and is expected to grow at a decent pace during the forecast period. Obesity is linked to a variety of joint problems, particularly those affecting the knee, such as knee discomfort and osteoarthritis. Worldwide obesity has tripled since 1975, according to a fact sheet provided by the World Health Organization (WHO). In 2016, 1.9 billion people were overweight, with over 650 million adults falling into this category.

Hyaluronic Acid Injections For Joint Pain Market, By Application

Hospital Pharmacies
Retail Pharmacies
Others

Based on Application, the market is bifurcated into, Hospital Pharmacies, Retail Pharmacies, and Others. Hospital pharmacies are leading the segment and it is expected to grow at a decent pace during the forecast period. In 2018, the hospital pharmaceutical category had the largest market share, followed by the retail sector. Its market share is predicted to continue to grow during the forecast period, owing to an increasing desire for joint pain treatment hospitals that require specialized employees for parenteral administration.

Hyaluronic Acid Injections For Joint Pain Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the Global Hyaluronic Acid Injections For Joint Pain Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Due to a huge patient pool, a growth in the senior population, rising obesity, and high adoption of innovative treatments for joint pain alleviation in the region, North America dominates the global joint pain injections market. During the forecast period, the region is expected to maintain its dominance. Furthermore, rising healthcare expenditures and increased investments are expected to drive the Hyaluronic Acid Injections For Joint Pain Market in the coming years.

Key Players

The major players in the Hyaluronic Acid Injections For Joint Pain Market are
Allergan
Zimmer Biomet
SEIKAGAKU
Pfizer
Sanofi
Bioventus
Flexion Therapeutics
Anika Therapeutics
Ferring.

1 INTRODUCTION

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET, BY TYPE

5.1 Overview
5.2 Knee and Ankle
5.3 Hip Joint
5.4 Others

6 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET, BY APPLICATION

6.1 Overview
6.2 Hospital Pharmacies
6.3 Retail Pharmacies
6.4 Others

7 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Middle East and Africa
- 7.5.2 South America

8 GLOBAL HYALURONIC ACID INJECTIONS FOR JOINT PAIN MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Allergan
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Zimmer Biomet
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 SEIKAGAKU
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Pfizer
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Sanofi
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Bioventus
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Flexion Therapeutics
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Anika Therapeutics
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Ferring
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments